文档介绍：:..脑利钠肽临床应用的研究进展[1]SudohT,KangawaK,MinaminoN,[J].Nature,1988,332(10):78-86[2]MarcV,JozefB,:molecularaspectsfJLEurJHeartFailure,:261-268[3]KollerKJ,[J].Circulation,1992,86(4):1081-1088[4].ChoyAM,:adualnatriureticpeptidesystempotentiallyinvolvedincirculatioryhomeostasisfJl•ClinSci(Lond),1992,83(5):519-520[5]SoleilhacJM,LucasE,-kDaprotein,identifiedasneutralendopeptiidase-,caninactivateatrialnatriureticpeptideinthevascularendothelium[J].Molpharmacol,1992,41(4):609-614[6]iWS,ElkayamU,HortonDP,,pensateedcongestiveheartfailure[J].NEnglJMed,200,343:246-253[7]YancyCW,SaltzbergMT,BerkowitzRL,(fromtheFUSIONITrial)[J].AmJCardiol,2004,94:595-601[8]ArosonD,(humanB-typenatriureticpeptide)reducesplasmaendothelin-pensatedcongestiveheartfailure[J].AmJCardiol,2002,90:435-438[9]HansK,-typenatriureticpeptide(BNP)andN-terminalproBNPinpatientswithend-stageheartfailuresupportedbyaleftventricularassistdevice[J].Clinchen,2004,50(9):1670-1672[10]